Stanford University researchers released information indicating that in hospitalized patients with severe COVID-19, the virus can cause production of autoantibodies that can, in effect, cause the body to attack itself and result in inflammatory diseases.
Myopia is a global epidemic that is driven in part by educational pressures, especially in Asian populations.
American Society of Retinal Specialists program to drive awareness and action around retinal diseases that put millions at risk for blindness.
Orbis, with support from FedEx, is offering training that will develop ophthalmologists’ skills to treat diabetic retinopathy in China.
The company announced that inebilizumab-cdon produces rapid and sustained B-cell depletion in African Americans with neuromyelitis optica spectrum disorder.
A recent report by Heru Inc. has found that visual field (VF) results from re:Vive, its wearable testing platform, have a strong association to the ZEISS Humphrey Field Analyzer (HFA).
The eyeglasses were reportedly designed to help the wearer reach enlightenment and drive away evil, according to Sotheby’s London, which will host the auction next month.
Bath, who invented the Laserphaco Probe for treating cataracts, is the first African-American woman inducted into the National Inventors Hall of Fame.
Glaukos has entered into a licensing agreement with Attillaps Holdings Inc., giving it an exclusive license to research, develop, manufacture and commercialize Attillaps’ proprietary library of investigational pharmaceutical compounds that target the eradication of Demodex mites.
According to Samsung Bioepis and Biogen, ranibizumab-nuna becomes the first ophthalmology biosimilar to gain FDA approval in the United States.
A retrospective review was performed to describe changes in corneal thickness and to identify the incidence of posterior corneal changes characteristic of keratoconus, following DMEK surgery. Here’s what investigators found.
Mutations in this glaucoma-associated gene may be commonly reported in many other neurodegenerative diseases.
Researchers conducting a case-control surveillance of COVID-19 vaccination during pregnancy found that spontaneous abortions did not increase as a result of vaccinations.
Investigators are working on the development of an intranasal subunit vaccine that provides durable local immunity against inhaled pathogens.
TearLab, MellingMedical reach an agreement to enhance early detection of dry eye disease in veterans.
A team of investigators have found that a molecular mechanism drives the progression of uveal melanoma, an often lethal eye cancer in adults.
Researchers found that the effectiveness of the vaccine held for about 6 months in most adults, but began to be less effective at that time point.
Unilateral ptosis can be the first symptom related to other causes that are traumatic, myogenic, neurogenic, or mechanical in nature.
Investigators at Dartmouth College have found that eye contact during a conversation makes the discussion more appealing to its participants.
Lisa Nijm, MD, JD, discusses the brand-new Real World Ophthalmology conference, designed to support ophthalmologists starting practice.
Children’s Hospital of Philadelphia and Stanford University School of Medicine will lead the $5.4 million study ,with patient recruitment beginning in late 2021 or early 2022.
AbbVie and REGENXBIO announced a strategic partnership to develop and commercialize RGX-314, an investigational gene therapy for wet age-related macular degeneration, diabetic retinopathy and other chronic retinal diseases.
Despite varied results, the company will submit a New Drug Application for pegcetacoplan for geographic atrophy to the FDA early next year.
The new virtual conference will debut on Sept. 18, and can help young ophthalmologists solve the small problems before they become bigger problems.
Horizon Therapeutics announced Tuesday the enrollment of the first patient in its Phase 4 clinical trial analyzing TEPEZZA® for the treatment of thyroid eye disease.
OD-OS’s teleguidance offering addresses the lack of experts and also benefits teaching in retina laser care.
The gene-based AAVCOVID vaccine employs a unique adeno-associated viral vector technology that was shown in non-clinical, nonhuman primate studies to enable protection from SARS-CoV-2 challenge and to induce sustained antibody and cellular immune responses from a single dose for up to a year.
Why instillation of topical corticosteroids may be associated with greater ptosis and higher rate of failed ptosis repair
A study in the United Arab Emirates reported a possible link between adverse ocular events and a COVID-19 vaccination.
Researchers believe the vial has the potential to transform the way corneal grafts are preserved and will provide scientists with a platform to develop customized preservation solutions.
.png "Optometry Times"){kind=logo}
